MyFinsight
Home
About
Contact
Back
Income Statement
Amneal Pharmaceuticals, Inc. (AMRX)
source: myfinsight.com
Download
Download image
Affordable Medicines
Segment
$433,425K
Amneal Specialty
Pharma Segment
$128,043K
Av KARESegment
$163,040K
Net revenue
$724,508K
(3.24%↑ Y/Y)
(credit) charges related
to legal matters,...
$390K
(155.79%↑ Y/Y)
Gross profit
$286,253K
(14.53%↑ Y/Y)
Cost of goods sold
$438,255K
(-3.01%↓ Y/Y)
Operating income (loss)
$111,372K
(16.66%↑ Y/Y)
Intellectual property legal
development expenses
$2,017K
Research and development
$47,964K
(33.03%↑ Y/Y)
Restructuring and other
charges
$1,024K
(365.45%↑ Y/Y)
Selling, general and
administrative
$124,266K
(6.70%↑ Y/Y)
Income (loss) before
income taxes
$51,711K
(153.42%↑ Y/Y)
Total other expense,
net
-$59,661K
(20.52%↑ Y/Y)
Foreign exchange gain
(loss), net
$8,256K
(3251.15%↑ Y/Y)
Other income, net
$1,604K
(-63.21%↓ Y/Y)
Net income (loss)
$35,610K
(112.13%↑ Y/Y)
Provision for income taxes
$16,101K
(345.02%↑ Y/Y)
Increase in tax
receivable agreement...
-$4,420K
(67.12%↑ Y/Y)
Interest expense, net
-$65,101K
(0.94%↑ Y/Y)
Back